Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Provided By GlobeNewswire
Last update: Sep 23, 2025
– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement –
Read more at globenewswire.comNASDAQ:CYCN (12/12/2025, 12:16:02 PM)
1.5
-0.18 (-10.71%)
Find more stocks in the Stock Screener
